{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:44:50Z","timestamp":1791654290267,"version":"4.3.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","funder":[{"DOI":"10.13039\/501100001409","name":"DST","doi-asserted-by":"publisher","award":["SEED\/TIASN\/002\/2016"],"award-info":[{"award-number":["SEED\/TIASN\/002\/2016"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMP"],"published-print":{"date-parts":[[2021,8,16]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Psoriasis is an autoimmune disease of the skin with lapsing episodes of hyperkeratosis,\nirritation, and inflammation. Numerous traditional and novel drug delivery systems\nhave been used for better penetration through psoriatic barrier cells and also for retention in the\nskin. As there is no effective remedy for better penetration, and retention is there because of the\nabsence of an ideal carrier for effective and safe delivery of antipsoriatic drugs.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p>The main objective of this project is to develop a Squalene integrated NLC based carbopol\n940 gel to create a local drug depot in the skin for improved efficacy against psoriasis.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Homogenization method is used for the formulation of Nanostructured Lipid Carrier,\nwhich was characterized on the basis of size, entrapment efficiency, polydispersity index (PDI), viscosity,\nspreadability, DSC, zeta potential, % in vitro release, in vitro skin permeation and retention\nstudies, physical storage stability studies. In vivo studies can use other alternative models for induction\nof psoriasis by severe redness, swelling macroscopically, and microvascular dilation edema\nlasting for 10 days. Furthermore, histopathology study was done to asses changes in the skin.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The optimized formulation of nanostructured lipid carrier-based gel has shown significant\nand sustained release of clobetasol propionate. Furthermore, this formulation has also shown\nretention in skin because of squalene as it is a sebum derived lipid, which shows an affinity towards\nthe sebaceous gland.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1874467213666200628135552","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T17:03:25Z","timestamp":1593450205000},"page":"399-411","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Development and Characterization of a Clobetasol Propionate Nanostructured Lipid Carrier-Based Gel for the Treatment of Plaque Psoriasis"],"prefix":"10.1016","volume":"14","author":[{"given":"Ankita","family":"Dadwal","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics; I.S.F. College of Pharmacy, GhalKalan, Ferozpur, G.T road, Moga-146001, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Mishra","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics; I.S.F. College of Pharmacy, GhalKalan, Ferozpur, G.T road, Moga-146001, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0866-179X","authenticated-orcid":true,"given":"Raj K.","family":"Narang","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics; I.S.F. College of Pharmacy, GhalKalan, Ferozpur, G.T road, Moga-146001, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"ref=1","first-page":"519","volume":"51","author":"Afifi T.","year":"2005","unstructured":"Afifi T.; de Gannes G.; Huang C.; Zhou Y.; Topical therapies for psoriasis: Evidence-based review. Can Fam Physician 2005,51(4),519-525","journal-title":"Can Fam Physician"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","volume":"32","author":"Lowes M.A.","year":"2014","unstructured":"Lowes M.A.; Su\u00e1rez-Fari\u00f1as M.; Krueger J.G.; Immunology of psoriasis. Annu Rev Immunol 2014,32,227-255","journal-title":"Annu Rev Immunol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1080\/09546630601123835","volume":"18","author":"Mazzotta A.","year":"2007","unstructured":"Mazzotta A.; Esposito M.; Carboni I.; Schipani C.; Chimenti S.; Clobetasol propionate foam 0.05% as a novel topical formulation for plaque-type and scalp psoriasis. J Dermatolog Treat 2007,18(2),84-87","journal-title":"J Dermatolog Treat"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.addr.2012.09.021","volume":"64","author":"Mehnert W.","year":"2012","unstructured":"Mehnert W.; M\u00e4der K.; Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 2012,64,83-101","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.addr.2007.04.012","volume":"59","author":"M\u00fcller R.H.","year":"2007","unstructured":"M\u00fcller R.H.; Petersen R.D.; Hommoss A.; Pardeike J.; Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev 2007,59(6),522-530","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jdermsci.2006.06.003","volume":"43","author":"Proksch E.","year":"2006","unstructured":"Proksch E.; F\u00f6lster-Holst R.; Jensen J-M.; Skin barrier function, epidermal proliferation and differentiation in eczema. J Dermatol Sci 2006,43(3),159-169","journal-title":"J Dermatol Sci"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1185\/03007990903512156","volume":"26","author":"Simpson E.L.","year":"2010","unstructured":"Simpson E.L.; Atopic dermatitis: A review of topical treatment options. Curr Med Res Opin 2010,26(3),633-640","journal-title":"Curr Med Res Opin"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jconrel.2015.12.010","volume":"223","author":"Mathes C.","year":"2016","unstructured":"Mathes C.; Melero A.; Conrad P.; Vogt T.; Rigo L.; Selzer D.; Prado W.A.; De Rossi C.; Garrigues T.M.; Hansen S.; Guterres S.S.; Pohlmann A.R.; Beck R.C.R.; Lehr C.M.; Schaefer U.F.; Nanocarriers for optimizing the balance between interfollicular permeation and follicular uptake of topically applied clobetasol to minimize adverse effects. J Control Release 2016,223,207-214","journal-title":"J Control Release"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1208\/s12249-011-9746-3","volume":"13","author":"Li B.","year":"2012","unstructured":"Li B.; Ge Z-Q.; Nanostructured lipid carriers improve skin permeation and chemical stability of idebenone. AAPS PharmSciTech 2012,13(1),276-283","journal-title":"AAPS PharmSciTech"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1504\/IJBNN.2012.051218","volume":"2","author":"Khurana S.","year":"2012","unstructured":"Khurana S.; Bedi P.; Jain N.; Development of nanostructured lipid carriers for controlled delivery of mefenamic acid. Int J Biomed Nanosci Nanotechnol 2012,2(3-4),232-250","journal-title":"Int J Biomed Nanosci Nanotechnol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jconrel.2015.12.010","volume":"223","author":"Mathes C.","year":"2016","unstructured":"Mathes C.; Melero A.; Conrad P.; Vogt T.; Rigo L.; Selzer D.; Prado W.A.; De Rossi C.; Garrigues T.M.; Hansen S.; Guterres S.S.; Pohlmann A.R.; Beck R.C.R.; Lehr C.M.; Schaefer U.F.; Nanocarriers for optimizing the balance between interfollicular permeation and follicular uptake of topically applied clobetasol to minimize adverse effects. J Control Release 2016,223,207-214","journal-title":"J Control Release"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/jphp.12543","volume":"68","author":"Silva L.A.D.","year":"2016","unstructured":"Silva L.A.D.; Andrade L.M.; de S\u00e1 F.A.; Marreto R.N.; Lima E.M.; Gratieri T.; Taveira S.F.; Clobetasol-loaded nanostructured lipid carriers for epidermal targeting. J Pharm Pharmacol 2016,68(6),742-750","journal-title":"J Pharm Pharmacol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1208\/s12248-013-9550-y","volume":"16","author":"Aljuffali I.A.","year":"2014","unstructured":"Aljuffali I.A.; Sung C.T.; Shen F.M.; Huang C.T.; Fang J.Y.; Squarticles as a lipid nanocarrier for delivering diphencyprone and minoxidil to hair follicles and human dermal papilla cells. AAPS J 2014,16(1),140-150","journal-title":"AAPS J"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"216","DOI":"10.4103\/0975-1483.83765","volume":"3","author":"Ekambaram P.","year":"2011","unstructured":"Ekambaram P.; Abdul H.S.; Formulation and evaluation of solid lipid nanoparticles of ramipril. J Young Pharm 2011,3(3),216-220","journal-title":"J Young Pharm"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1163\/1568562054798536","volume":"16","author":"Vernon B.","year":"2005","unstructured":"Vernon B.; Martinez A.; Gel strength and solution viscosity of temperature-sensitive, in-situ-gelling polymers for endovascular embolization. J Biomater Sci Polym Ed 2005,16(9),1153-1166","journal-title":"J Biomater Sci Polym Ed"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1166\/jnn.2015.9183","volume":"15","author":"de Andrade D.F.","year":"2015","unstructured":"de Andrade D.F.; Fontana M.C.; Pohlmann A.R.; Guterres S.S.; Carlos R.; Beck R.; Nanoencapsulation of clobetasol propionate decreases its penetration to skin layers without changing its relative skin distribution. J Nanosci Nanotechnol 2015,15(1),875-879","journal-title":"J Nanosci Nanotechnol"},{"key":"ref=17","first-page":"65","volume":"76","author":"Nakaguma H.","year":"1995","unstructured":"Nakaguma H.; Kambara T.; Yamamoto T.; Rat ultraviolet ray B photodermatitis: An experimental model of psoriasis vulgaris. Int J Exp Pathol 1995,76(1),65-73","journal-title":"Int J Exp Pathol"},{"key":"ref=18","first-page":"289","volume":"Vol. 6","author":"Patel N.","year":"2016","unstructured":"Patel N.; Patel P.; Meshram D.;  A development and validation of RP-HPLC method for simultaneous estimation of Nadifloxacin and Clobetasol Propionate in its pharmaceutical dosage form 2016,Vol. 6,289-304","journal-title":"A development and validation of RP-HPLC method for simultaneous estimation of Nadifloxacin and Clobetasol Propionate in its pharmaceutical dosage form"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0378-5173(01)00810-9","volume":"228","author":"Agarwal R.","year":"2001","unstructured":"Agarwal R.; Katare O.P.; Vyas S.P.; \n                        \n                        in vitro\n                        \n                     Int J Pharm 2001,228(1-2),43-52","journal-title":"Int J Pharm"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-3-319-18227-8_3","author":"Hartman R.I.","year":"2016","unstructured":"Hartman R.I.; Kimball A.B.;  Handbook of Psoriasis and Psoriatic Arthritis 2016,17-26","journal-title":"Handbook of Psoriasis and Psoriatic Arthritis"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jconrel.2012.06.024","volume":"162","author":"Campbell C.S.","year":"2012","unstructured":"Campbell C.S.; Contreras-Rojas L.R.; Delgado-Charro M.B.; Guy R.H.; Objective assessment of nanoparticle disposition in mammalian skin after topical exposure. J Control Release 2012,162(1),201-207","journal-title":"J Control Release"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0149-2918(98)80032-5","volume":"20","author":"Gordon M.L.","year":"1998","unstructured":"Gordon M.L.; The role of clobetasol propionate emollient 0.05% in the treatment of patients with dry, scaly, corticosteroid-responsive dermatoses. Clin Ther 1998,20(1),26-39","journal-title":"Clin Ther"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.curtheres.2005.06.010","volume":"66","author":"Feldman S.R.","year":"2005","unstructured":"Feldman S.R.; Relative efficacy and interchangeability of various clobetasol propionate vehicles in the management of steroid-responsive dermatoses. Curr Ther Res Clin Exp 2005,66(3),154-171","journal-title":"Curr Ther Res Clin Exp"}],"container-title":["Current Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/183255","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/183255\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/183255","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T22:57:01Z","timestamp":1746572221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/183255\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,16]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,8,16]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1874467213666200628135552","relation":{},"ISSN":["1874-4672"],"issn-type":[{"value":"1874-4672","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,16]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-01-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}